ACE inhibitors in myocardial infarction

In general, patients initiated on ACE inhibitors in myocardial infarction (MI) have demonstrated a reduction in overall mortality by about 20% to 30%. This benefit is most profound in patients with symptomatic congestive heart failure and their therapy should be continued indefinitely. The renin-angiotensin-aldosterone system (RAAS) regulates aldosterone release in the body via the action […]